Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hangzhou Phecdamed Co., Ltd.

Clinical trials sponsored by Hangzhou Phecdamed Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill aims to restore strength in aging muscles Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1 Completed 3

New pill aims to restore strength in aging muscles

Disease control Recruiting now

This study tests a new capsule, TJ0113, in 204 older adults (age 60+) with sarcopenia, a condition causing muscle loss and weakness. Participants take the capsule or a placebo daily for 26 weeks. The main goal is to see if the drug improves walking speed, a key measure of muscle …

Phase 2 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Disease control

Last updated Aug 07, 2026 00:00 UTC